This compound is a chiral compound used as a chiral resolution agent in pharmaceutical manufacturing. It features two carboxylic acid groups and two ester-linked benzoyl groups, giving it a distinct stereochemical configuration.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 17026-42-5
[S-(R',R')]-2,3-Bis(benzoyloxy)butanedioic acid compd. with [S-(R',R')]-[1-ethyl-2-(phenylmethoxy)propyl]hydrazine
pharmaceutical intermediate
(+)-Dibenzoyl-D-tartaric acid monohydrate
pharmaceutical intermediate
Vipivotide tetraxetan Linker
pharmaceutical intermediate
6-(1-Methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4(1H)-one
pharmaceutical intermediate
4-Chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazine
pharmaceutical intermediate
Tert-butyl 4-(5-(4-fluorobenzoyl)pyrimidin-2-yl)piperazine-1-carboxylate
pharmaceutical intermediate
Dibenzoyltartaric acid
pharmaceutical intermediate
(-)-Dibenzoyl-L-tartaric acid monohydrate
pharmaceutical intermediate
(2S,3S)-2,3-dibenzoyloxybutanedioic acid
YONLFQNRGZXBBF-KBPBESRZSA-N
C1=CC=C(C=C1)C(=O)O[C@@H]([C@@H](C(=O)O)OC(=O)C2=CC=CC=C2)C(=O)O